Senior insider sale
Chief Financial Officer at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$114.6K
5.49K shares
What this filing means
GOLDAN KEITH A. plans to sell 5.49K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $114.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/9/2026ACC: 0001959173-26-000771
Officer· Chief Financial Officer
Since Jun 2022
5.49K
Shares to sell
$114.6K
Approx. market value
3.41K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/6/2026
3.41KTotal acquired3.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/6/2026 | Restricted Stock Vesting Compensation | 3.41K | — |
| Total | 3.41K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.08K
Market value
$42.9K
2/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.41K
Market value
$71.7K
2/9/2026
Total
Units
5.49K
Value
$114.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/6/2026 | 2.08K | $42.9K | — | Completed |
| Planned — Approximate Date | ||||
2/9/2026 | 3.41K | $71.7K | NASDAQ | Planned |
| Total | 5.49K | $114.6K | ||